Quantcast
Last updated on April 19, 2014 at 1:20 EDT

Latest Peptides Stories

2012-12-05 12:24:29

BASKING RIDGE, N.J., Dec. 5, 2012 /PRNewswire/ -- Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced that David J. Mazzo, PhD, President and CEO, will be presenting at the Oppenheimer 23(rd) Annual Healthcare Conference at 11:10 a.m. ET on Wednesday, December 12, 2012 in the Louis XVI Room at the Waldorf Astoria in New York City. The presentation will include an overview of the Company's...

2012-12-03 04:20:44

LUND, Sweden, December 3, 2012 /PRNewswire/ -- NeuroVive announces publication of the results of a Phase I clinical trial of lead product CicloMulsion(R) in the scientific journal Clinical Drug Investigation. The paper highlights that the intravenous cyclosporine formulation CicloMulsion(R) demonstrates bioequivalence and improved tolerability when compared with Sandimmune(R) Injection. The mitochondrial medicine company NeuroVive Pharmaceutical today announces...

2012-09-18 23:11:20

The absence of a specific type of neuron in the brain can lead to obesity and diabetes in mice report researchers in The EMBO Journal. The outcome, however, depends on the type of diet that the animals are fed. A lack of AgRP-neurons, brain cells known to be involved in the control of food intake, leads to obesity if mice are fed a regular carbohydrate diet. However, animals that are deficient in AgRP-neurons but which are raised on a high-fat diet are leaner and healthier. The differences...

2012-09-12 06:31:02

BASKING RIDGE, N.J., Sept. 12, 2012 /PRNewswire/ -- Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced that David J. Mazzo, PhD, President and CEO, will be presenting at the UBS Global Life Sciences Conference at 2:00 p.m. ET on September 19, 2012 at the Grand Hyatt in New York City. The presentation will include an overview of the Company's pipeline with emphasis on the lead development program, the...

2012-08-29 06:25:07

BASKING RIDGE, N.J, Aug. 29, 2012 /PRNewswire/ -- Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced that David J. Mazzo, PhD, President and CEO, will be presenting at the Stifel Nicolaus Healthcare Conference 2012 at 3:15 p.m. ET on September 5, 2012 at the Four Seasons Hotel in Boston, MA. The presentation will include an overview of the Company's pipeline with emphasis on the lead development program,...

2012-08-25 23:00:08

LifeCell Reviews of South Beach Skincare´s Anti-Aging Cream have been popping all over the internet with the media going crazy for it. Healthavenger.com reveals whether this product delivers on its promise of helping women look radiant and beautiful for as long as they live. Houston, TX (PRWEB) August 25, 2012 A LifeCell Review of South Beach Skincare´s Anti-Aging Cream takes an in-depth look at this product that claims to start working the minute it is applied. This wonder...

2012-08-14 11:59:20

'High microcystin concentrations occur only at low nitrogen-to-phosphorus ratios in nutrient-rich Canadian lakes' Nutrient pollution, one of the greatest threats to our freshwater resources, is responsible for the algal blooms that blanket our lakes and waterways in summer months. Large blooms of cyanobacteria ('blue green algae') can cause fish kills, increase the cost of drinking water treatment, devalue shoreline properties, and pose health risks to people, pets, and wildlife. A new...

2012-08-08 06:24:03

BASKING RIDGE, N.J., Aug. 8, 2012 /PRNewswire/ -- Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced that Ellen McDonald, MBA, Senior Vice President and Chief Business Officer, will be presenting at the Canaccord Genuity 32nd Annual Growth Conference in Boston, MA at 4:30 p.m. ET on August 14, 2012 at the InterContinental Boston Hotel. The presentation will include an overview of the Company's pipeline...

2012-08-07 06:26:10

BASKING RIDGE, N.J., Aug. 7, 2012 /PRNewswire/ -- Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced that David J. Mazzo, PhD, President and CEO, will be presenting at the 2012 Wedbush PacGrow Life Sciences Conference at 8:30 a.m. ET on August 14, 2012 in the Gamshoge Room of the Le Parker Meridien in New York City. The presentation will include an overview of the Company's pipeline with emphasis on the...

2012-07-31 06:25:54

NEW YORK, July 31, 2012 /PRNewswire/ -- Synergy Pharmaceuticals Inc. (Nasdaq: SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that poster presentations on plecanatide that will be given at three separate Gastroenterology society meetings this fall. Plecanatide is currently being developed for the treatment of patients suffering with chronic constipation (CIC) and irritable bowel syndrome-constipation predominant (IBS-C). Plecanatide is an...